February, 2024
February 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
26272829  
Super results in transfusion-dependent patients on ruxolitinib – Francesco Passamonti
Jun 17, 2023, 15:37

Super results in transfusion-dependent patients on ruxolitinib – Francesco Passamonti

It was a great honor to present at EHA 2023 on behalf of all investigators results of the ACE-536-MF-001 trial on luspatercept in patients with myelofibrosis and anemia. Super results in transfusion-dependent patients on ruxolitinib: a 32% rate of transfusion-independency over time with 53% of the patients with >50% reduction of transfusion burden. This allowed to keep stable the dose of ruxolitinib and the spleen size. All with a safe profile!

Source: Francesco Passamonti/Linkedin